We are proud to mark our 35th anniversary! Since our founding, we have been committed to improving patient care by bringing new and innovative treatments to patients across Central and Eastern Europe.
Founded in 1989 by pharmacist Tone Strnad, Medis has grown to become one of the largest commercialization partners for the world’s leading pharmaceutical and biotech manufacturers in the region. Known for its values and ethical approach, Medis has earned the trust of partners, healthcare professionals and patients alike.
35 years since its establishment, Medis now employs 400 people, delivering a diversity of services and solutions to 18 markets, thousands of patients and hundreds of healthcare organizations.
Reflecting on the company’s journey, Tone Strnad,founder of Medis, said:
“Looking back over the past three and a half decades, I am immensely proud of what Medis has achieved. Our journey started with a vision to make healthcare more accessible. We have grown into a trusted partner for multinational pharma companies, constantly evolving as a company based on knowledge and values such as teamwork, respect and responsibility.”
Maja Strnad Cestar, CEO of Medis, envisions further expansion:
“The unique passion and expertise of our team and the strength of our partnerships inspire our enthusiasm for the future. Together, we are committed to bringing innovative medicines, treatments and solutions to patients in the region. Our goal is to increase our impact in the field of innovative medicines and rare diseases and introduce new methods and treatments to make a lasting difference to the lives of the people we touch.”
To celebrate this milestone, we have created a timeline that highlights key events in our history.
In addition to being one of the leading companies for the commercialization of rare and specialty portfolios and medical products in the region and staying ahead of the competition, Medis remains committed to strengthening its sustainability efforts, with a focus on employee development and giving back to society. This is very much part of the Medis culture.
Among the many organizations and projects Medis supports, the company is a proud sponsor of the International Medis Awards for Medical Research, which recognizes outstanding scientific achievements in medicine and pharmacy across the region.
Medis is also a founding member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service distributors specializing in rare and specialty portfolios.